Latest Vagus nerve stimulation Stories
Cyberonics Launches #MyLifeIsBright Campaign and #HealthyAndBright Promotion During Epilepsy Awareness Month to Shine a Light on Hope for Hard-to-Treat Cases HOUSTON, Nov.
Subcutaneous Trigeminal Nerve Stimulation (sTNS) for the Treatment of Neuropsychiatric Disorders LOS ANGELES, Oct. 21, 2014 /PRNewswire/ - NeuroSigma(®), Inc.
HOUSTON, Oct. 14, 2014 /PRNewswire-USNewswire/ -- On November 19, 2014, Houston, TX-based Cyberonics, Inc.
Market Research Report Titled Global Neurostimulation Devices Market Analysis Size And Segment Forecasts To 2020 available at GrandViewResearch database.
Latest research presented at 2014 American Academy of Otolaryngology Meeting in Orlando Sept. 19-23 MINNEAPOLIS and ORLANDO, Fla., Sept.
HOUSTON, Sept. 2, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), today announced results from the ANTHEM-HF clinical study.
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug.
HOUSTON, Aug. 21, 2014 /PRNewswire/ -- Cyberonics, Inc.
DALLAS, Aug. 6, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "U.S. Orthopedic Large Joint Reconstruction Device Market" and "U.S.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.